CompletedPhase 2NCT00030225

Phase 2 Evaluation of the ELAD System in the Management of Acute Liver Failure

Studying Acute liver failure

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Vital Therapies, Inc.
Principal Investigator
Patrick J Maguire, MD, PhD
VitaGen
Intervention
ELAD(biological)
Enrollment
19 enrolled
Eligibility
18-50 years · All sexes
Timeline
20022003

Study locations (7)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00030225 on ClinicalTrials.gov

Other trials for Acute liver failure

Additional recruiting or active studies for the same condition.

See all trials for Acute liver failure

← Back to all trials